Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zura Bio Ltd. (ZURA:NASDAQ), powered by AI.
Zura Bio Ltd. is currently trading at $3.52. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Zura Bio Ltd. on Alpha Lenz.
Zura Bio Ltd.'s P/E ratio is -4.8.
“Zura Bio Ltd. trades at a P/E of -4.8 (undervalued) with modest ROE of -55.3%.”
Ask for details →Zura Bio Ltd. is a crucial player in the biotechnology sector, specializing in the development of innovative therapeutics targeting immune disorders and other critical diseases. The primary focus of Zura Bio is to create pioneering drugs and treatment protocols that enhance patient outcomes, particularly for conditions that currently have limited treatment options. Its contributions are significant in the pharmaceutical and healthcare industries, where ongoing research and development are key to addressing unmet medical needs. Within the financial markets, Zura Bio attracts attention from investors and analysts due to its potential for groundbreaking advancements and its role in the growing biopharma space. The company's operations might also influence sectors like healthcare equipment and supply chain management, as new treatments can drive demand for related medical services and products. Overall, Zura Bio Ltd. plays a pivotal role in advancing medical research and improving quality of life through its commitment to biotechnological innovation.
“Zura Bio Ltd. trades at a P/E of -4.8 (undervalued) with modest ROE of -55.3%.”
Ask for details →Zura Bio Ltd. (ticker: ZURA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 30 employees. Market cap is $331M.
The current price is $3.515 with a P/E ratio of -4.82x and P/B of 3.26x.
ROE is -55.28%.